Learn More
OBJECTIVE To investigate putative changes in cortical excitability of patients affected by early-onset mild dementia by means of transcranial magnetic stimulation (TMS) and to verify whether a peculiar neurophysiological profile may contribute to characterise Alzheimer's disease (AD) vs frontotemporal dementia (FTD). METHODS Motor threshold and(More)
This study aimed to investigate whether transcranial magnetic stimulation (TMS) can induce selective working memory (WM) deficits of visual-object versus visual-spatial information in normal humans. Thirty-five healthy subjects performed two computerized visual n-back tasks, in which they were required to memorize spatial locations or abstract patterns. In(More)
Standard markers in cerebrospinal fluid (CSF), as soluble amyloid beta 1-42 (Abeta1-42) and total tau protein (t-tau), may contribute to dementia subtypes diagnostic accuracy. Yet, their sensitivity to assess the different degree of cognitive deficit is not fully clarified. Our study analyses Abeta1-42 and t-tau CSF levels in different cohorts of(More)
In neuropsychological practice, the availability of effective and reliable tests is crucial. The Symbol Digit Modalities Test (SDMT) is widely used because it is easy to administer, reliable and also evaluates information processing speed. We set out to obtain normative data (currently unavailable for the Italian population) for the oral version of this(More)
Transthyretin (TTR) is a 55 kDa homotetrameric protein. TTR in the cerebral spinal fluid (CSF) is primarily synthesized by the choroid plexus. TTR can bind to the beta-amyloid peptide and a number of familial amyloidosis diseases (familial amyloid polyneuropathy) have been associated with its allele variants. In a transgenic mice model overexpression of TTR(More)
We investigated whether the cerebrospinal fluid (CSF) biomarkers beta-amyloid 1-42 (Abeta1-42), total tau (t-tau) protein and tau protein phosphorylated at threonine 181 (p-tau181) could discriminate Alzheimer's disease (AD) from vascular dementia (VD) patients. CSF samples of Abeta1-42, t-tau, and p-tau181 were collected from probable AD (n=35), probable(More)
Sirs: Neurological complications of thyroid disease are numerous and well known in the case of thyrotoxicosis or myxoedema, while the features of neurological involvement in Hashimoto’s thyroiditis have not been clearly characterised. Hashimoto’s encephalopathy (HE) is a severe and rare disorder, associated with Hashimoto’s thyroiditis, whose pathogenesis(More)
Sirs: Posterior cortical atrophy (PCA) was first described by Benson in1988 as a variant of Alzheimer’s disease (AD) with atypical clinical presentation [2]. At onset, patients usually complain of visual symptoms such as visual agnosia and show features of Balint’s and Gerstmann’s syndromes or apraxic disorders [1, 3]. Memory and language are impaired later(More)
BACKGROUND AND PURPOSE Noncontrast CT ASPECTS has been investigated as a predictor of outcome in patients with acute ischemic stroke. Our purpose was to investigate whether CTA source images are a better predictor of clinical and radiologic outcomes than NCCT ASPECTS in candidates for endovascular stroke therapy. MATERIALS AND METHODS CT scans of patients(More)
BACKGROUND Few data exist on malignant middle cerebral artery infarction (MMI) among patients with acute ischemic stroke (AIS) after endovascular treatment (ET). Numerous predictors of MMI evolution have been proposed, but a comprehensive research of patients undergoing ET has never been performed. Our purpose was to find a practical model to determine(More)
  • 1